What the DEA’s Marijuana Rescheduling May Mean for People with ADHD

The DEA’s historic shift to reclassify marijuana as a Schedule III drug would ease restrictions on research and accessibility to medical cannabis — and some worry it could increase the risk of substance use disorder in people with ADHD.